Get started
Author

Anton Ivanovich Korbut

Observed names: A I Korbut, A Korbut, A. I. Korbut, ANTON I. KORBUT, Anton I Korbut, Anton I. Korbut, Anton Korbut, А. I. KORBUT, А. И. Корбут
ORCID: 0000-0003-3502-5892
Observed ORCID: 0000-0003-3502-5892
OpenAlex ID: A5033098716
Glucose Variability: How Does It Work?
2021 · Vadim V. Klimontov, Olga V. Saik, et al. · International Journal of Molecular Sciences · 127
PDF
SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes
2020 · Anton I. Korbut, Iuliia S. Taskaeva, et al. · International Journal of Molecular Sciences · 106
PDF
Anti-Inflammatory Effects of SGLT2 Inhibitors: Focus on Macrophages
2025 · Elena Y Rykova, Vadim V Klimontov, et al. · International Journal of Molecular Sciences · 78
PDF
Albuminuric and non-albuminuric patterns of chronic kidney disease in type 2 diabetes
2018 · Vadim V. Klimontov, Anton I. Korbut · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 46
Empagliflozin alleviates podocytopathy and enhances glomerular nephrin expression in db/db diabetic mice
2020 · Vadim V Klimontov, Anton I Korbut, et al. · World Journal of Diabetes · 28
Serum Cytokines and Growth Factors in Subjects with Type 1 Diabetes: Associations with Time in Ranges and Glucose Variability
2023 · Vadim V. Klimontov, Kamilla R. Mavlianova, et al. · Biomedicines · 25
PDF
Carotid Artery Disease in Subjects with Type 2 Diabetes: Risk Factors and Biomarkers
2021 · Vadim V. Klimontov, Elena A. Koroleva, et al. · Journal of Clinical Medicine · 23
PDF
Multiplex Bead Array Assay of a Panel of Circulating Cytokines and Growth Factors in Patients with Albuminuric and Non-Albuminuric Diabetic Kidney Disease
2020 · Vadim V. Klimontov, Anton I. Korbut, et al. · Journal of Clinical Medicine · 22
PDF
Risk factors and urinary biomarkers of non-albuminuric and albuminuric chronic kidney disease in patients with type 2 diabetes
2019 · Anton I Korbut, Vadim V Klimontov, et al. · World Journal of Diabetes · 19
Factors associated with trabecular bone score in postmenopausal women with type 2 diabetes and normal bone mineral density
2022 · Olga N Fazullina, Anton I Korbut, et al. · World Journal of Diabetes · 15
Incretin-based therapy: renal effects
2016 · Anton Ivanovich Korbut, Vadim Valerievich Klimontov · Diabetes Mellitus · 13
PDF
Relationships between Body Composition and Plasma Levels of Pancreatic, Gut, and Adipose Tissue Hormones in db/db Mice, a Model of Type 2 Diabetes Mellitus
2019 · A. I. Korbut, V. V. Klimontov, et al. · Bulletin of Experimental Biology and Medicine · 11
Glucose Variability in People with Type 1 Diabetes: Associations with Body Weight, Body Composition, and Insulin Sensitivity
2024 · Julia F. Semenova, Anton Yu. Yushin, et al. · Biomedicines · 10
Normoalbuminuric chronic kidney disease in diabetes
2018 · V V Klimontov, A I Korbut · Terapevticheskii arkhiv · 10
PDF
Empagliflozin: a new strategy for nephroprotection in diabetes
2017 · Anton Ivanovich Korbut, Vadim Valer'evich Klimontov · Diabetes Mellitus · 10
PDF
Urinary Markers of Tubular Injury and Renal Fibrosis in Patients with Type 2 Diabetes and Different Phenotypes of Chronic Kidney Disease
2023 · Anton I. Korbut, Vyacheslav V. Romanov, et al. · Life · 9
PDF
In Vitro Photodynamic Inactivation of Mycobacterium Tuberculosis by Methylene Blue
2019 · D. А. BREDIKHIN, S. D. NIKONOV, et al. · Tuberculosis and lung diseases · 5
PDF
The Relationships between Serum Levels of Adipokines, Body Fat Distribution, and Subcutaneous Microvasculature in Type 2 Diabetic Subjects
2018 · VADIM KLIMONTOV, DINARA BULUMBAEVA, et al. · Diabetes · 4
Risk factors for decreased bone mineral density in men with type 2 diabetes.
2021 · Olga N. Fazullina, Anton I. Korbut, et al. · Diabetes Mellitus · 3
PDF
Clinical and laboratory characteristics of the patterns of chronic kidney disease in patients with type 2 diabetes
2020 · Vadim V. Klimontov, Anton I. Korbut, et al. · Diabetes Mellitus · 3
PDF
Overweight and obesity in patients with type 1 diabetes: associations with vascular complications and biomarkers of vascular remodeling
2025 · V. V. Klimontov, A. Yu. Yushin, et al. · Diabetes Mellitus · 2
PDF
Factors associated with high glucose variability in patients with type 1 diabetes
2022 · V. V. Klimontov, Ju. F. Semenova, et al. · Diabetes Mellitus · 2
PDF
Empagliflozin, Linagliptin, and Metformin Differentially Affect Renal PI3K/Akt and MAPK/ERK Signaling Pathways in db/db Diabetic Mice
2026 · Anton I. Korbut, Elizaveta A. Ananishnikova, et al. · International Journal of Molecular Sciences · 1
Effects of empagliflozin on biomarkers of renal injury, fibrosis and low-grade inflammation in patients with type 2 diabetes
2026 · A. I. Korbut, V. V. Romanov, et al. · Diabetes Mellitus · 1
PDF
Urinary Excretion of Biomolecules Related to Cell Cycle, Proliferation, and Autophagy in Subjects with Type 2 Diabetes and Chronic Kidney Disease
2024 · Anton I. Korbut, Vyacheslav V. Romanov, et al. · Biomedicines · 1
PDF
Works count: 48
Citation count: 578
H-index: 11
I10-index: 15
Year
Topic
Type